Authors: Yip-Schneider, MT Sweeney, CJ Jung, SH Crowell, PL Marshall, MS

Citation: Mt. Yip-schneider et al., Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells, J PHARM EXP, 298(3), 2001, pp. 976-985

Authors: Yip-Schneider, MT Lin, A Marshall, MS

Citation: Mt. Yip-schneider et al., Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2, BIOC BIOP R, 280(4), 2001, pp. 992-997

Authors: Yip-Schneider, MT Miao, WY Lin, A Barnard, DS Tzivion, G Marshall, MS

Citation: Mt. Yip-schneider et al., Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association, BIOCHEM J, 351, 2000, pp. 151-159

Authors: Yip-Schneider, MT Barnard, DS Billings, SD Cheng, L Heilman, DK Lin, A Marshall, SJ Crowell, PL Marshall, MS Sweeney, CJ

Citation: Mt. Yip-schneider et al., Cyclooxygenase-2 expression in human pancreatic adenocarcinomas, CARCINOGENE, 21(2), 2000, pp. 139-146

Authors: Yip-Schneider, MT Lin, A Barnard, D Sweeney, CJ Marshall, MS

Citation: Mt. Yip-schneider et al., Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression, INT J ONCOL, 15(2), 1999, pp. 271-279